Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Esketamine on Oxygenation in Thoracoscopic Surgery
NCT06822088Phase 4Not yet recruiting
- Start
- Mar 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine (3 arms). Primary endpoint: Oxygenation Index (OI). Planned start Mar 2025; status: not yet recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on NCT06822088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06822088.